ANKRD29: A Potential Drug Target and Biomarker (G147463)

Target Name: ANKRD29

NCBI ID: G147463

ANKRD29

ANKRD29: A Potential Drug Target and Biomarker

Ankyrin repeat domains (ANKRDs) are a class of non-coding DNA sequences that have been identified in various organisms as being involved in various cellular processes. One such ANKRD, ANKRD29, has been shown to have unique functions in various biological processes and is now considered as a potential drug target and biomarker.

ACKNOWLEDGMENT

The ANKRD29 gene has been studied extensively, and its functions continue to be understood. This article aims to provide a comprehensive overview of ANKRD29, including its functions, potential drug targets, and potential use as a biomarker.

FUNCTIONS OF ANKRD29

ANKRD29 is a non-coding DNA sequence that is composed of a unique array of 29 amino acid residues. It is located in the cytoplasm and is involved in various cellular processes.

One of the most significant functions of ANKRD29 is its role in the regulation of mitochondrial dynamics. Mitochondria are organelles that are responsible for generating energy in the form of ATP and are essential for various cellular processes. ANKRD29 is known to be involved in the regulation of mitochondrial fission and fusion, which are critical processes for maintaining cellular energy production.

In addition, ANKRD29 is also involved in the regulation of cellular signaling pathways. It has been shown to be involved in various signaling pathways, including the TOR signaling pathway, the PI3K/Akt signaling pathway, and the NF-kappa-B signaling pathway. These signaling pathways are involved in various cellular processes, including cell growth, apoptosis, and inflammation.

POTENTIAL DRUG TARGET

The ANKRD29 gene has been shown to be involved in various cellular processes that are important for human health. As a result, ANKRD29 has been considered as a potential drug target.

The ANKRD29 protein is known to be involved in the regulation of mitochondrial dynamics and cellular signaling pathways. It is thought to play a role in the regulation of cellular processes that are important for human health, such as the development and progression of cancer, the aging process, and neurodegenerative diseases.

Given its potential involvement in various cellular processes, ANKRD29 has been identified as a potential drug target. Several studies have shown that ANKRD29 can be targeted by small molecules, including inhibitors of the TOR signaling pathway, which are known to have therapeutic potential for various diseases.

POTENTIAL BIOMARKER

The ANKRD29 gene has also been shown to be involved in the regulation of various cellular processes that are important for human health. As a result, ANKRD29 has been considered as a potential biomarker for various diseases.

Studies have shown that ANKRD29 is involved in the regulation of cellular processes that are important for the development and progression of cancer. It is thought to play a role in the regulation of cell cycle progression, apoptosis, and angiogenesis, which are critical processes for the development of cancer.

Additionally, ANKRD29 has also been shown to be involved in the regulation of cellular signaling pathways, including the TOR signaling pathway, the PI3K/Akt signaling pathway, and the NF-kappa-B signaling pathway. These signaling pathways are involved in various cellular processes, including cell growth, apoptosis, and inflammation.

SUMMARY

In conclusion, ANKRD29 is a non-coding DNA sequence that is involved in various cellular processes that are important for human health. Its functions include the regulation of mitochondrial dynamics, cellular signaling pathways, and the regulation of cellular processes that are important for the development and progression of cancer. As a result, ANKRD29 has

Protein Name: Ankyrin Repeat Domain 29

The "ANKRD29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD29 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets